Report of foreign issuer [Rules 13a-16 and 15d-16]

Shareholders' Equity - Schedule of Company's Option Activity (Details)

v3.25.2
Shareholders' Equity - Schedule of Company's Option Activity (Details) - USD ($)
6 Months Ended
Dec. 31, 2024
Jun. 30, 2025
Schedule of Weighted Average Exercise Prices Share Options [Abstract]    
Number of options, Grants (in Shares)   24,000,000
Weighted average exercise price, Grants   $ 0.01
Weighted average remaining contractual terms, Grants   10 years
Weighted average of the grant date fair value, Grants   $ 0
Number of options, expired (in Shares)   (30,000)
Weighted average exercise price, expired  
Weighted average remaining contractual terms, expired  
Number of options, Ending (in Shares) 124,829,000 148,799,000
Weighted average exercise price, Ending $ 0.03 $ 0.03
Weighted average remaining contractual terms, Ending 7 years 1 month 6 days 7 years 1 month 6 days
Aggregate intrinsic value, Ending (in Dollars)
Weighted average of the grant date fair value, Ending
Number of options, Vested and expected to vest (in Shares)   148,799,000
Weighted average exercise price, Vested and expected to vest   $ 0.03
Weighted average remaining contractual terms, Vested and expected to vest   7 years 1 month 6 days
Aggregate intrinsic value, Vested and expected to vest (in Dollars)  
Weighted average of the grant date fair value, Vested and expected to vest  
Number of options, Exercisable (in Shares)   60,283,375
Weighted average exercise price, Exercisable   $ 0.06
Weighted average remaining contractual terms, Exercisable   5 years 9 months 18 days
Aggregate intrinsic value, Exercisable (in Dollars)  
Weighted average of the grant date fair value, Exercisable